Thursday Feb 2 | BioSpace
Pozen, Inc. Release: Preventive Aspirin Use Less Than Optimal in...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia NEW ORLEANS-- --POZEN Inc.
Thursday Feb 2 | MediLexicon
Aspirin Is Underused By Stroke Survivors
Roughly 40% of patients who survive a stroke do not take aspirin on a daily basis, despite established guidelines that recommend its use for secondary prevention in this population, investigators announced at the 2012 International Stroke Conference.
Thursday Feb 2 | Sys-Con Media
POZEN's Digital Advisory Board to Speak at Annual ePharma Summit
A POZEN-sponsored panel discussion titled, "Transforming the Pharma Industry - Breakthrough Perspectives from Digital Leaders," will be held on Tuesday, February 7, 2012 from 10:50 - 11:25 a.m. at the Sheraton New York Hotel & Towers.
Drug partnerships: Not all positive, not all negative
Pozen CEO John Platchetka likens the drug partnering process to a relay race. One runner at full speed finishes and hands the baton to another runner at full speed to finish the race.
POZEN Inc (POZN) Posts Large Volume Increase, 375,000 Shares Trade Hands.
The stock last traded at $4.28, up from its previous close of $4.27. Separately, analysts at Brean Murray cut their price target on shares of POZEN Inc from $9.00 to $7.00 in a research note to investors on Friday, November 25th.
Also on Topix